By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination Challenge
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > News > Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination Challenge
Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination Challenge
News

Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination Challenge

Last updated: 31/07/2025 2:36 AM
Published: 31/07/2025
Share
SHARE

ST. PAUL, Minn., July 30, 2025 /PRNewswire/ — In a significant development in an ongoing legal dispute, the U.S. Patent and Trademark Office (USPTO) has issued a final rejection of all claims in U.S. Patent No. 11,660,056 held by Rampart IC, LLC related to a radiation shielding device. The decision follows a request for reexamination by Egg Medical, Inc., which argued that Rampart’s ‘056 patent covered technology that had already been invented—some examples dating as far back as the 1960s.

- Advertisement -

Egg Medical’s reexamination request arose out of a lawsuit that Rampart filed in federal court in 2024, in which Rampart alleged that Egg Medical had infringed on its ‘056 patent. However, after the USPTO twice rejected all claims in the ‘056 patent, the federal judge overseeing the case stayed the proceedings pending the outcome of the reexamination. In July 2025, the USPTO issued a final rejection of all claims, citing multiple prior inventions—two of which were developed by Egg Medical.

- Advertisement -

“The remarkable part of this lawsuit is that Egg Medical never sold any product that fell within the scope of Rampart’s now-rejected patent claims,” said Robert F. Wilson, MD, CEO of Egg Medical. “Egg Medical respects prior intellectual property. The USPTO rejecting the claims in Rampart’s asserted ‘056 patent validates what we have been saying all along.”

- Advertisement -

Gavin Philipps, Chief Commercial Officer at Egg Medical, added, “The lawsuit was harmful to our company, as Rampart’s sales team at times suggested to customers that we were infringing on their ‘056 patent—an assertion that was never true. We’re pleased that the USPTO has thoroughly and repeatedly rejected all of Rampart’s claims in that patent, and we’re glad our customers now have clarity.”

- Advertisement -

Rampart IC may still respond to the USPTO’s final rejection or appeal to the Patent Trial and Appeal Board. After three rounds and a sweeping final rejection, however, Rampart’s options are dwindling.

- Advertisement -

About Egg Medical

- Advertisement -

Egg Medical is a global leader in radiation protection, founded with the goal to reduce the radiation exposure of healthcare workers who use x-ray imaging to perform life-saving diagnostic and therapeutic procedures for patients. More information about Egg Medical is available at https://eggmedical.com.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2740854/EGG_MEDICAL__EggNest_Complete_System.jpg

- Advertisement -

Logo – https://mma.prnewswire.com/media/2740853/EGG_MEDICAL__Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/egg-medical-announces-us-patent-and-trademark-office-issues-final-rejection-of-all-claims-in-rampart-ics-radiation-shield-patent-following-a-reexamination-challenge-302517464.html

- Advertisement -
BRAHMA AI, Hakuhodo Technologies Partner to Scale High-Fidelity Digital Humans Across Japan and APAC
Lamborghini Super Trofeo Europe: PuteraLevet claim clean sweep of victories
Best ACV Gummies 2026 Report: True Keto Fusion Analyzed in New Year Keto-ACV Industry Analysis
Kolmar Korea Wins Legal Battle Over Sun Care Technology Leakage Against Intercos Korea
Mobile Money accounted for $2 trillion in transactions in 2025, doubling since 2021 as active accounts continue to grow
TAGGED:allandannounceschallengeclaimseggfinalfollowingic’sissuesmedicalnewsofficepatentradiationrampartreexaminationrejectionshieldtrademarku.s.
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Health

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNews Wire
GlobeNews Wire
14/09/2025
Ferrero Group reports Consolidated Financial Statements for the 2024/2025 Financial Year
Rivermate Launches as a Unified Global Employer of Record Platform, Bringing Together Eos Global Expansion, Serviap Global, and Hightekers’ EOR Operations
Reliance Digital Launches ‘Baaptaa’, a Father’s Day Campaign Celebrating the Many Expressions of Fatherhood
HCW Biologics Announces Pricing of $1.5 Million Follow-On OfferingPriced At-The-Market Under NASDAQ Rules
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?